Skip to main content

Table 4 Covariance analysis of ORRs of clinical symptoms between the IFNα1b group and the control group after 7 days of treatment

From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

 

FAS

P

PPS

P

Statistics F

Statistics F

Covariate effect

0.557

0.457

0.317

0.574

Sex comparison

0.929

0.337

1.493

0.224

Between-group comparison

4.781

0.030

3.649

0.048

Sex and Group

0.006

0.941

0.043

0.836